Early Clinical Trials Of Targeted Therapies Highlighted At AACR-NCI-EORTC Meeting
FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy
Flavopiridol Plus Cisplatin Tested In Phase II Trial
Trial Combines Drugs Against Blood Vessel Formation
Bevacizumab And Irinotecan May Increase Survival Of GBM
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- Lou Weiner: Poetry and art help us imagine my mother’s world as a hidden child of the Holocaust
- ACOG says it will no longer accept federal funding
- Andrea Werblin Reid’s unflinching poetry documents the realities of cancer care, clinical trials, and loss
Her collection, “To See Yourself As You Vanish,” will be published three years after her death - When public service ends abruptly, do books provide solace? An escape? Perspective?
Former NIH and FDA employees tell us what they are reading in 2025 - Brown University reaches agreement with Trump administration to restore funding
- The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five states
Honoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party”